• Users Online: 754
  • Print this page
  • Email this page
STATE-OF-THE-ART REVIEW
Year : 2017  |  Volume : 10  |  Issue : 4  |  Page : 227-236

Upcoming therapeutic options for progressive multiple sclerosis


Department of Neurology, Medical University of Vienna, Vienna, Austria

Correspondence Address:
Fritz Leutmezer
Department of Neurology, Medical University of Vienna, Vienna
Austria
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.7707/hmj.809

Rights and Permissions

Although a wide range of therapeutic options are available for relapsing–remitting multiple sclerosis (MS), the therapeutic landscape for progressive forms of the disease is highly unsatisfactory. Therefore, the identification of effective therapies for progressive MS (PMS) is a highly relevant challenge for the global MS medical community. To achieve this, a better understanding of the mechanisms involved in PMS is required through novel clinical trial designs, new drug repurposing strategies and new methods of collaboration in identifying effective therapies. In this review, we discuss the first compounds already available for PMS as well as other therapies currently undergoing phase II and III clinical trials.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed214    
    Printed14    
    Emailed0    
    PDF Downloaded38    
    Comments [Add]    

Recommend this journal